Catalyst Wire Dossier Catalyst Wire Dossier

OCU400

· Ocugen
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for OCU400, covering 2025-08-06 to 2026-03-05. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 3 Study Of OCU400 Gene Therapy for the Treatment Of Retinitis Pigmentosa [Phase 3]

See pricing